دورية أكاديمية

Myelopreservation with Trilaciclib in Patients Receiving Topotecan for Small Cell Lung Cancer: Results from a Randomized, Double-Blind, Placebo-Controlled Phase II Study

التفاصيل البيبلوغرافية
العنوان: Myelopreservation with Trilaciclib in Patients Receiving Topotecan for Small Cell Lung Cancer: Results from a Randomized, Double-Blind, Placebo-Controlled Phase II Study
المؤلفون: Hart, Lowell L., Ferrarotto, Renata, Andric, Zoran G., Beck, J. Thaddeus, Subramanian, Janakiraman, Radosavljevic, Davorin Z., Zaric, Bojan, Hanna, Wahid T., Aljumaily, Raid, Owonikoko, Taofeek K., Verhoeven, Didier, Xiao, Jie, Morris, Shannon R., Antal, Joyce M., Hussein, Maen A.
المساهمون: G1 Therapeutics, Inc.
المصدر: Advances in Therapy ; volume 38, issue 1, page 350-365 ; ISSN 0741-238X 1865-8652
بيانات النشر: Springer Science and Business Media LLC
سنة النشر: 2020
مصطلحات موضوعية: Pharmacology (medical), General Medicine
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1007/s12325-020-01538-0
DOI: 10.1007/s12325-020-01538-0.pdf
DOI: 10.1007/s12325-020-01538-0/fulltext.html
الإتاحة: https://doi.org/10.1007/s12325-020-01538-0Test
حقوق: https://creativecommons.org/licenses/by-nc/4.0Test ; https://creativecommons.org/licenses/by-nc/4.0Test
رقم الانضمام: edsbas.900D6361
قاعدة البيانات: BASE